Publicou 6 edições por ano
ISSN Imprimir: 1543-1649
ISSN On-line: 1940-4352
Indexed in
ANERGY TO SYNERGY-THE ENERGY FUELING THE RXCOVEA FRAMEWORK
RESUMO
We write to introduce our novel group formed to confront some of the issues raised by the COVID-19 pandemic. Information about the group, which we named "cure COVid for Ever and for All" (RxCOVEA), its dynamic membership (changing regularly), and some of its activities-described in more technical detail for expert perusal and commentary-are available upon request.
-
De Clercq, E. and Li, G., Approved Antiviral Drugs over the past 50 Years, Clin. Microbiol. Rev, vol. 29, no. 3, pp. 695-747, 2016.
-
Du, S.Q. and Yuan, W., Mathematical Modeling of Interaction between Innate and Adaptive Immune Responses in COVID-19 and Implications for Viral Pathogenesis, J. Med. Virol., 2020 (ahead of print). DOI: 10.1002/jmv.25866.
-
Gandhi, M., Yokoe, D.S., and Havlir, D.V., Asymptomatic Transmission, the Achilles' Heel of Current Strategies to Control COVID-19, N.Engl. J Med., 2020 (ahead of print). DOI: 10.1056/nejme2009758.
-
He, X., Lau, E.H., Wu, P., Deng, X., Wang, J., Hao, X., Lau, Y.C., Wong, J.Y., Guan, Y., Tan, X., and Mo, X., Temporal Dynamics in Viral Shedding and Transmissibility of COVID-19, Nat. Med, vol. 26, no. 5, pp. 672-675, 2020.
-
Jewell, N.P., Lewnard, J.A., and Jewell, B.L., Caution Warranted: Using the Institute for Health Metrics and Evaluation Model for Predicting the Course of the COVID-19 Pandemic, Ann. Intern. Med., 2020 (ahead of print). DOI: 10.7326/m20-1565.
-
Zhavoronkov, A., Vanhaelen, Q., and Oprea, T.I., Will Artificial Intelligence for Drug Discovery Impact Clinical Pharmacology?, Clin. Pharmacol. Ther., vol. 107, no. 4, pp. 780-785,2020.